STRATEGIC ANTIBIOTIC DECISION-MAKING AT THE FORMULARY LEVEL

被引:0
|
作者
QUINTILIANI, R
NIGHTINGALE, CH
CROWE, HM
COOPER, BW
BARTLETT, RC
GOUSSE, G
机构
[1] HARTFORD HOSP,DEPT ADM,HARTFORD,CT 06115
[2] HARTFORD HOSP,DEPT PHARM SERV,HARTFORD,CT 06115
[3] UNIV CONNECTICUT,SCH MED,DEPT MED,FARMINGTON,CT 06032
[4] UNIV CONNECTICUT,SCH MED,DEPT PATHOL,FARMINGTON,CT 06032
[5] UNIV CONNECTICUT,SCH PHARM,FARMINGTON,CT 06032
来源
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The proliferation of antimicrobial agents introduced for the treatment of increasingly complex infectious diseases, coupled with the obligation to provide the best possible medical care in keeping with hospital fiscal constraints, has created a need for strategic decision-making about antibiotics at the formulary level. The following experience at the Hartford Hospital, a 1,000-bed tertiary-care facility, represents an example of an antibiotic management system based on a multidisciplinary approach that utilizes infectious disease physicians, clinical microbiologists, hospital epidemiologists, and pharmacists.
引用
收藏
页码:S770 / S777
页数:8
相关论文
共 50 条